Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 32Head & Neck 4Tumor-Agnostic 3Thoracic 3Other solid neoplasm 2CNS 2Breast 2Sarcoma 1Myeloid 1Gynecologic 1

Conditions

Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thyroid Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Histiocytosis 1Brain Neoplasms 1

Interventions

Carboplatin 347pembrolizumab 325Pemetrexed 247Cisplatin 220Paclitaxel 148Nivolumab 139durvalumab 134Docetaxel 112osimertinib 110atezolizumab 106Specimen Handling 91Drug Therapy 87Radiotherapy 86Magnetic Resonance Spectroscopy 77Etoposide 77Radiosurgery 72Gemcitabine 72Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 53cemiplimab 47tislelizumab 46Blood Specimen Collection 43Taxes 34Cetuximab 34Biopsy 33Standard of Care 32Platinum 32Injections 32Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Panitumumab × Thoracic × 1 year × Clear all
NCT07094204 2026-05-18

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
364 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

NCT07094113 2026-02-12

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Amgen

Phase 1 Recruiting
434 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡